Big Gain For MBX Biosciences, Inc.
Mon, Sep 22, 2025 at 07:48 PM
MBX Biosciences, Inc. (MBX:NASDAQ) soared at $20, a gain of 100%. On Mon, Sep 22, 2025, MBX:NASDAQ hit a New 2-Week High of $20. The stock got featured on our News Catalysts scanner on Mon, Sep 22, 2025 at 07:11 PM in the 'PUBLIC OFFERING' category. From Mon, Sep 08, 2025, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Sep 22, 2025 at $26.45 with a volume of 27M+.
About MBX Biosciences, Inc. (MBX:NASDAQ)
MBX Biosciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders.
Top 10 Gainers:
- Boxlight Corporation (BOXL:NASDAQ), 205.77%
- AgriFORCE Growing Systems Ltd. (AGRI:NASDAQ), 137.76%
- Movella Holdings Inc. (MVLA:NASDAQ), 125%
- SRAX, Inc. (SRAX:NASDAQ), 105.45%
- MBX Biosciences, Inc. (MBX:NASDAQ), 100%
- Qualigen Therapeutics, Inc. (QLGN:NASDAQ), 94.72%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 94.44%
- ARB IOT Group Limited (ARBB:NASDAQ), 63.04%
- Nvni Group Limited (NVNI:NASDAQ), 62.22%
- Metsera, Inc. (MTSR:NASDAQ), 60.8%